After weighting, baseline characteristics were balanced between the two groups, except for index year, prescribers specialty, BMI, and feeding difficulty (Table 1 and Supplementary Table 1)
In addition, patients indicated that these drugs have side effects that include nausea, diarrhea, constipation, and headaches
As consumer interest in prescription weight loss treatment access through telehealth platforms continues to grow heading into 2026, updated service disclosures for Hims GLP-1 Weight Lossa prescription-only offeringhave recently become publicly available
The conversation has moved faster
General Principles For Planning And Design Of Multi-Regional Clinical Trials E17 (ICH, 2017)
Among consumers actively trying to lose weight in 2025, 11% globally 1 and 18% in the US 2 reported using them